Management of Vrikk Rog Through Ayurvedic Principles: A Case-based Perspective
DOI:
https://doi.org/10.48165/ajm.2026.9.01.53Keywords:
Ayurveda, Panchkarma, Mutraghata, Mutrakshaya, Mutravaha srotas, Shaman Chikitsa, Shodhan and Vrikk rogAbstract
Chronic Kidney Disease (CKD) or Vrikk Rog, though not described explicitly in Ayurvedic texts, can be understood within the framework of Mutravah Strotodushti, Rakta Dushti, and Dhatukshaya. Traditional medical approaches often focus on managing blood sugar, blood pressure, and symptoms, whereas Ayurveda views CKD as a result of an imbalance in the Tridoshas (Vata, Pitta and Kapha), particularly Vata and Kapha imbalances. The accumulation of Ama (toxins) and improper digestion (Agni Dushti) lead to kidney dysfunction, which is often exacerbated by lifestyle factors, poor diet, and stress. This case study presents a 54-year-old male patient diagnosed with CKD, who was admitted to Jeena Sikho Lifecare Limited Hospital, Derabassi, and treated with an extensive Ayurvedic approach. Management was planned according to the principles of Chikitsa Siddhanta, focusing on Shodhan and Shaman therapies. Throughout the IPD stay, the patient showed notable improvements observed in urinary output, general well-being, and energy levels. The holistic approach, integrating Ahar, Vihar, and Aushadhi, demonstrated significant enhancement in renal function and quality of life, supporting the efficacy of Ayurvedic management in chronic renal conditions.
References
Levey, A. S., & Coresh, J. (2012). Chronic kidney disease. The Lancet, 379(9811), 165–180. https://doi.org/10.1016/S0140-6736(11)60178-5
Centers for Disease Control and Prevention. (2022). Chronic kidney disease in the United States, 2021. https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html
Yu, A. S. L., Chertow, G. M., Luyckx, V., Marsden, P. A., Skorecki, K., & Taal, M. W. (Eds.). (2019). Brenner and Rector's the kidney (11th ed.). Elsevier.
National Institute of Diabetes and Digestive and Kidney Diseases. (2017). Symptoms & causes of chronic kidney disease. U.S. Department of Health and Human Services. https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/symptoms-causes
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2013). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements, 3(1), 1–150. https://doi.org/10.1038/kisup.2012.73
National Kidney Foundation. (2023). ACE inhibitors and ARBs. https://www.kidney.org/kidney-topics/ace-inhibitors-and-arbs
Myhre, J., & Sifris, D. (2024). How chronic kidney disease is treated: From diet and drugs to dialysis and transplant. Verywell Health. https://www.verywellhealth.com/kidney-disease-treatments-4170060
International Society of Nephrology, & Kidney Disease: Improving Global Outcomes. (n.d.). CKD early identification and intervention toolkit. https://www.theisn.org/initiatives/toolkits/ckd-early-screening-intervention/
Kushner, P., Khunti, K., Cebrián, A., Amod, A., & Buse, J. B. (2024). Early identification and management of chronic kidney disease: A narrative review of the crucial role of primary care practitioners. Advances in Therapy, 41(10), 3757–3770. https://doi.org/10.1007/s12325-024-02957-z
Zisser, M., & Aran, D. (2024). Transformer-based time-to-event prediction for chronic kidney disease deterioration. Journal of the American Medical Informatics Association, 31(4), 980–990. https://doi.org/10.1093/jamia/ocae025
Jawad, K. M. T., Verma, A., & Amsaad, F. (2024). AI-driven predictive analytics approach for early prognosis of chronic kidney disease using ensemble learning and explainable AI [Preprint]. TechRxiv. https://doi.org/10.36227/techrxiv.171837833.39991005/v1
Cukoski, S., Lindemann, C. H., Arjune, S., Todorova, P., Brecht, T., Kühn, A., Schmidt, B., Mollenhauer, M., Grundmann, F., & Liebau, M. C. (2023). Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—A randomized controlled trial. Cell Reports Medicine, 4(11), Article 101283. https://doi.org/10.1016/j.xcrm.2023.101283
Aggarwal, A., Sokiya, G., & Sharma, G. (2023). Management of chronic kidney disease: An Ayurveda case study. Journal of Ayurveda and Integrated Medical Sciences, 8(7), 250–256. https://jaims.in/jaims/article/view/2508
Tiwari, H., Dang, P., Badyal, S., & Dhawan, P. (2024). Chronic kidney disease pathogenesis in Ayurveda parlance: A review. International Ayurvedic Medical Journal, 8(2), 138–145. https://doi.org/10.46607/iamj06p8022024
Ramteke, R. S., Thakar, A. B., Trivedi, A. H., & Patil, P. D. (2012). Clinical efficacy of Gokshura-Punarnava Basti in the management of microalbuminuria in diabetes mellitus. Ayu, 33(4), 537–541. https://doi.org/10.4103/0974-8520.110535
Banthanal, P., & Kulkarni, M. (2024). Critical review on Niruha Basti with special reference to Charaka Samhita. Journal of Ayurveda and Integrated Medical Sciences, 9(10), 59–64. https://doi.org/10.21760/jaims.9.10.9
Bairagi, B. A., Gadkari, P. U., & More, M. S. Clinical evaluation of Varunadi Taila Vrikkabasti in the management of renal calculi.
Naik, S. S., Cardozo, B. S. M., Bondre, M. M., & Das, S. K. (2022). A clinical study to evaluate the efficacy of Dashang Sunthi Lepa in management of Sandhi Shotha and Shula. World Journal of Pharmacy and Pharmaceutical Sciences, 8(12), 135–145.
Rawat, V., Kumar, V., & Verma, S. (2020). Role of Shirodhara by Brahmi Taila in essential hypertension: A conceptual study. World Journal of Pharmacy and Pharmaceutical Sciences, 6(10), 154–158.
Manish, A., Chaudhary, G., Singh, M., & Richa. (2024). A case study for integrating Ayurvedic Panchkarma therapies for management of chronic kidney disease. AYUSHDHARA, 11(6), 208–223. https://doi.org/10.47070/ayushdhara.v11i6.1818
Garud, S., Chaudhary, A., & Kotecha, M. (2017). Pathya-Apathya: A peculiarity of Ayurveda. International Journal of Ayurvedic and Herbal Medicine, 7(4), 2635–2642. https://doi.org/10.18535/ijahm/v7i4.01
Hospital & Institute of Integrated Medical Sciences. (n.d.). What is DIP diet? How does it help cure kidney disease? https://hiims.in/blog/dip-diet-for-kidneys/
Suman, & Joshi, N. K. (2024). Millets: Forgotten grains with potential health benefits in Ayurveda with special reference to Kodrava. Journal of Ayurveda and Integrated Medical Sciences, 9(7), 230–236. https://doi.org/10.21760/jaims.9.7.35
Breivik, H., Borchgrevink, P. C., Allen, S. M., Rosseland, L. A., Romundstad, L., Breivik Hals, E. K., Kvarstein, G., & Stubhaug, A. (2008). Assessment of pain. British Journal of Anaesthesia, 101(1), 17–24. https://doi.org/10.1093/bja/aen103
Brodovicz, K. G., McNaughton, K., Uemura, N., Meininger, G., Girman, C. J., & Steven, H. (2009). Reliability and feasibility of methods to quantitatively assess peripheral edema. Clinical Medicine & Research, 7(1–2), 21–31. https://doi.org/10.3121/cmr.2009.825
Chopra, R. N., Ghosh, S., Ghosh, B. N., & De, P. (1923). The pharmacology and therapeutics of Boerhaavia diffusa (Punarnava). Indian Medical Gazette, 58(5), 203.
Das, C., & Singh, M. P. (2023). A pharmaco-therapeutic study of Gokshur in Mutrakriccha Vyadhi with special reference to urinary tract infection. International Journal of Ayurveda and Pharma Research, 17–23.
JS, D., Borole, K. D., Pandit, V. A., Dey, D., Sahane, S. S., & Karandikar, M. N. Evaluation of nephro-, hepato-, and gastro-toxic potential of aqueous extract of Dashamula.
Sharma, R., Jadhav, M., Choudhary, N., Kumar, A., Rauf, A., Gundamaraju, R., Al-Ghamdi, S., & Awad, M. G. (2022). Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and in vivo validation. Frontiers in Nutrition, 9, Article 1063118.
Byadgi, P. S., Kanashetti, D. S., Tiwari, R., Maurya, B. N., Rana, M., Dwivedi, V. K., & Sharma, R. (2021). Shunthi (Zingiber officinale Rosc.): A miraculous medicinal plant. International Journal of Advanced Research in Medical Chemistry, 3(1), 8–13.
Rathva, D., Pal, P., Parmar, D., Upadhyay, S., & Upadhyay, U. A basic review on carom seeds oil.
Bhola, S., & Rao, M. P. (2016). Are Rasapanchaka physical effects or pharmacological effects? A detailed review. World Journal of Pharmacy and Research, 5(4), 404–415.
Sharma, S. A traditional therapeutic review of Pippali (Piper longum) and its root in classical Ayurvedic texts.
Gupta, P. C. (2012). Biological and pharmacological properties of Terminalia chebula Retz. (Haritaki): An overview. International Journal of Pharmacy and Pharmaceutical Sciences, 4(3), 62–68.
Bajpay, A., Nainwal, R. C., Singh, D., & Tewari, S. K. (2018). Medicinal value of Cyperus rotundus Linn: An updated review. Medicinal Plants, 10(3), 165–170.
Mishra, S., Dash, R., & Kumar, S. (2024). Chronic kidney disease in light of Ayurveda: A literary review on Vataj Pandu. International Journal of Ayurveda and Pharma Research, 12(4), 65–68. https://doi.org/10.47070/ijapr.v12i4.3193
Borkar, P., Yadav, V., Tiwari, R. R., & Samarth, R. M. (2022). A systematic review of potential candidates of herbal medicine in treatment of chronic kidney disease. Phytomedicine Plus, 2(4), Article 100361. https://doi.org/10.1016/j.phyplu.2022.100361
Patel, M., Patel, M., Patel, K., Wischnewsky, M., Stapelfeldt, E., Kessler, C. S., & Gupta, S. N. (2020). Deceleration of disease progress through Ayurvedic treatment in nondialysis stages IV-V patients with chronic renal failure: A quasi-experimental clinical pilot study with one-group pre- and postdesign and two premeasurements. The Journal of Alternative and Complementary Medicine, 26(5), 384–391. https://doi.org/10.1089/acm.2019.0419
Yan, Z., Wang, G., & Shi, X. (2021). Advances in the progression and prognosis biomarkers of chronic kidney disease. Frontiers in Pharmacology, 12, Article 785375.
Patankar, S., Gorde, A., Patankar, S., Raje, R., Devanpally, C., Ausekar, P., Deshpande, A., & Chitale, S. (2025). A prospective, randomized, open label, parallel group, comparative clinical trial to evaluate the safety and efficacy of combination of herbal oral capsule and rectal medication to improve gut health of type 2 diabetic patients having chronic kidney disease (CKD). Journal of Ayurveda and Integrative Medicine, 16(2), Article 100992.
Al Khodor, S., & Shatat, I. F. (2017). Gut microbiome and kidney disease: A bidirectional relationship. Pediatric Nephrology, 32(6), 921–931.
